IDH1 and astrocytoma (excluding glioblastoma): In terms of astrocytoma, the updated classification allowed to classify astrocytoma tumors more accurately, as well as, to predict the outcome of patients, and to select treatment strategy, according to the MGMT methylation or IDH status.